Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem. An adverse drug reaction (ADR) is a noxious and unintended response to a medicine occurring at doses normally used in man. Unlike a drug side effect, which is often a predictable secondary pharmacological action, an ADR is typically harmful and unexpected. Monitoring these reactions helps regulatory bodies ensure that medicines on the market remain safe for public use. Nurses sit at the frontline of patient care, making them uniquely positioned to spot these untoward reactions early during routine hospital or community ward rounds.
In Nigeria, post-market surveillance of medicines is coordinated by the National Agency for Food and Drug Administration and Control (NAFDAC). The ADR monitoring form serves as the primary tool for healthcare workers to report suspected drug toxicities. Because clinical trials involve limited sample sizes, rare or long-term safety issues often only surface after a drug reaches the general population. Reporting adverse events helps NAFDAC detect safety signals, issue warnings, change prescribing guidelines, or withdraw dangerous batches of medications from circulation. Without consistent local reporting, dangerous drug reactions specific to our population demographics might go completely unnoticed.
The official document used in Nigeria for reporting suspected adverse drug reactions is popularly known as the Yellow Form. It features a standardized layout divided into clear sections to capture essential clinical details without unnecessary administrative burden. While physical paper copies remain widely distributed in hospital wards and clinics, an electronic reporting system is also available through the NAFDAC website. Using this standardized format ensures that data collected from a primary health centre in a rural village can be easily compared and analyzed alongside data from a tertiary teaching hospital.
To make an ADR report useful for regulatory investigation, several core sections must be filled out accurately:
Not every sickness that occurs after taking a medicine is caused by that medicine. Causality assessment determines the likelihood that a specific drug caused the observed adverse event using established algorithms like the WHO scale (certain, probable, possible, unlikely). Nurses do not need to calculate complex statistical algorithms themselves, but they must provide clear timelines showing when the drug started and when the reaction appeared. Additionally, reactions are categorized by severity. A serious ADR is any untoward medical occurrence that results in death, requires inpatient hospitalization, causes persistent disability, or is life-threatening.
Once an ADR form is completed, it must reach the regulatory authorities promptly. Completed paper forms can be mailed, hand-delivered to NAFDAC zonal offices, or scanned and sent via designated email addresses. Many modern Nigerian teaching hospitals now have dedicated Pharmacovigilance or Drug and Therapeutics Committees that collect internal reports before forwarding them upstream. Follow-up is equally critical; if a patient's condition worsens or laboratory results become available after the initial submission, a follow-up report marked with the same reference number should be sent to update the file.
Nurses administer the majority of medications in inpatient settings and educate patients in outpatient clinics, placing them at the center of drug safety monitoring. Overcoming under-reporting is a major challenge in clinical practice; many nurses assume someone else will report an adverse event or view paperwork as an unnecessary chore. Cultivating a safety culture means recognizing that every submitted yellow form contributes to national drug safety. Patient education also falls within this scope—instructing clients to report unusual symptoms rather than silently stopping their prescribed medications safeguards compliance and therapeutic outcomes.